Seungwon Kim

Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer.

An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice.

Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788.

Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer.

Antivascular therapy of oral tongue squamous cell carcinoma with PTK787.

Growth inhibition of orthotopic anaplastic thyroid carcinoma xenografts in nude mice by PTK787/ZK222584 and CPT-11.

Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.

Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer.

Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.

Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.

Concurrent cetuximab and bevacizumab therapy in a murine orthotopic model of anaplastic thyroid carcinoma.

Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.

The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model.

Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer.

Reconstruction of the through-and-through anterior mandibulectomy defect: indications and limitations of the double-skin paddle fibular free flap.

Video rigid laryngeal endoscopy compared to laryngeal mirror examination: an assessment of patient comfort and clinical visualization.

Animal models of cancer in the head and neck region.

Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer.

Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.

Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis.

Antitumor effect of vandetanib through EGFR inhibition in head and neck squamous cell carcinoma.

Utility of positron-emission tomography/computed tomography imaging in the management of the neck in recurrent laryngeal cancer.

Incidental thyroid cancer found during surgery for head and neck squamous cell carcinoma.

First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.

A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: A role for transoral robotic surgery.

Predictive biomarkers to anti-VEGF therapy: progress toward an elusive goal.

Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.

Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma.

The mutational landscape of adenoid cystic carcinoma.

Extracapsular spread in head and neck carcinoma: Impact of site and human papillomavirus status.

Early squamous cell carcinoma of the oral tongue: comparing margins obtained from the glossectomy specimen to margins from the tumor bed.

A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma.

Clinical significance of intraparotid lymph node metastasis in primary parotid cancer.

Combination antiangiogenic therapy and radiation in head and neck cancers.

PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.

Quality of life in head and neck cancer patients: impact of HPV and primary treatment modality.

STAT3 oligonucleotide inhibits tumor angiogenesis in preclinical models of squamous cell carcinoma.

Transoral Robotic Surgery and the Unknown Primary: A Cost-Effectiveness Analysis.

Clinical outcome of patients with carcinoma ex pleomorphic adenoma of the parotid gland: a comparative study from a single tertiary center.

Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.

Robot-assisted level II-IV neck dissection through a modified facelift incision: initial North American experience.

Occult Primary Head and Neck Squamous Cell Carcinoma: Utility of Discovering Primary Lesions.

Is level V neck dissection necessary in primary parotid cancer?

Pectoralis major myofascial onlay and myocutaneous flaps and pharyngocutaneous fistula in salvage laryngectomy.

Hyalinizing clear cell carcinoma of the head and neck: Case series and update.

A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck.

Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.

Analysis of post-transoral robotic-assisted surgery hemorrhage: Frequency, outcomes, and prevention.

Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma.

Accuracy of computed tomography to predict extracapsular spread in p16-positive squamous cell carcinoma.

Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local Control.

Occupational Exposure to Diesel Particulate Matter in Municipal Household Waste Workers.

Robot-Assisted Neck Dissection Through a Modified Facelift Incision.

Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient Counseling.

Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.

Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer.

A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.

Robotic-assisted oropharyngeal reconstruction.

Oncologic outcomes of surgically treated early-stage oropharyngeal squamous cell carcinoma.

Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.

Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.

Cervical Osteomyelitis After Pharyngeal Surgical Manipulation.

Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinoma.